Karl Heinimann
- Pathology and Forensic Medicine top 0.5%
- Genetic factors in colorectal cancer 67
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 29
- Oncology top 2%
- Colorectal Cancer Treatments and Studies 24
- Colorectal Cancer Screening and Detection 21
- Genetics top 2%
- Genomic variations and chromosomal abnormalities 18
- BRCA gene mutations in cancer 6
- Molecular Biology top 5%
- RNA Research and Splicing 7
- DNA Repair Mechanisms 6
- Co-authors
- Oliver M. SieberIan TomlinsonMichael CrabtreeShirley V. HodgsonHuw ThomasLara LiptonRobin PhillipsSabine Schmid
- Journals
- New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (2 papers)Nature Communications (1 paper)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Karl Heinimann
105 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Pathology and Forensic Medicine 2.0k
- Cancer Research 971
- Oncology 1.5k
- Genetics 798
- Molecular Biology 1.4k
Countries citing papers authored by Karl Heinimann
This map shows the geographic impact of Karl Heinimann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Heinimann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Heinimann more than expected).
Fields of papers citing papers by Karl Heinimann
This network shows the impact of papers produced by Karl Heinimann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Heinimann. The network helps show where Karl Heinimann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Karl Heinimann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2020 | 5 | |
| 3 | 2019 | 13 | |
| 4 | DUOX2 Deficiency in Quebec: From Life-Threatening Compressive Goiter in Infancy to Lifelong Euthyroidism | 2018 | 1 |
| 5 | 2015 | 25 | |
| 6 | 2014 | 30 | |
| 7 | 2013 | 7 | |
| 8 | 2013 | 6 | |
| 9 | 2012 | 16 | |
| 10 | 2012 | 11 | |
| 11 | 2011 | 42 | |
| 12 | 2011 | 26 | |
| 13 | 2010 | 36 | |
| 14 | 2010 | 19 | |
| 15 | 2007 | 6 | |
| 16 | 2006 | 54 | |
| 17 | 2006 | 4 | |
| 18 | 2003 | 8 | |
| 19 | N-acetyltransferase 2 influences cancer prevalence in hMLH1/hMSH2 mutation carriers. | 1999 | 30 |
| 20 | 1998 | 62 |
About Karl Heinimann
Karl Heinimann is a scholar working on Pathology and Forensic Medicine, Cancer Research and Oncology, having authored 107 papers that have together received 3.8k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (67 papers), Cancer Genomics and Diagnostics (29 papers), Colorectal Cancer Treatments and Studies (24 papers), Colorectal Cancer Screening and Detection (21 papers), Genomic variations and chromosomal abnormalities (18 papers), RNA Research and Splicing (7 papers), DNA Repair Mechanisms (6 papers) and BRCA gene mutations in cancer (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.0k citations), Cancer Research (971 citations) and Oncology (1.5k citations). Karl Heinimann has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Oliver M. Sieber, Ian Tomlinson, Michael Crabtree, Shirley V. Hodgson, Huw Thomas, Lara Lipton, Robin Phillips, Sabine Schmid, Lauri A. Aaltonen and Marie-Luise Bisgaard. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.